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Zimbabwe is the only country in southern Africa with no 
reported African swine fever (ASF) outbreaks during 1993–
2014. However, the 2015 discovery of genotype II ASF virus 
in Zimbabwe indicates the reemergence of ASF in this coun-
try and suggests that this viral genotype may be spreading 
through eastern and southern Africa.
In many countries in Africa, pig farm production is re-strained by outbreaks of African swine fever (ASF), a 
highly contagious and rapidly spreading disease that causes 
high rates of death among infected pigs and for which there 
is no vaccine (1). In southern Africa, the epidemiology of 
the causative agent, ASF virus (ASFV), is further compli-
cated by the presence of sylvatic and domestic transmis-
sion cycles. The sylvatic cycle has been implicated in most 
outbreaks reported near national parks where infected wart-
hogs (Phacochoerus africanus) and soft tick (Ornithodoros 
spp.) vectors are present (1). The virus can be horizontally 
transmitted between pigs via the uncontrolled movement 
of virus-contaminated pig products and the feeding of swill 
containing infectious pig meat; transmission is also facili-
tated by the lack of adequate biosecurity measures (2).
Genotyping is used to determine relationships between 
ASFV strains (3). ASF became endemic in Eurasia after 
the spread of a genotype II ASFV from eastern Africa to 
Georgia in 2007 (4,5). The virus has continued to spread in 
Eurasia, and in 2014, it was detected in Lithuania and Po-
land, putting the European Union at risk (6). In eastern and 
southern Africa, genotype II ASFV has been described in 
Tanzania, Mauritius, and Mozambique (7). Zimbabwe had 
outbreaks caused by ASFV genotype I in 1990 and 1992 
and by genotype VIII in 1961. No further outbreaks were 
reported in Zimbabwe until July 2015, when ASF was de-
tected in domestic pigs in Mashonaland Central Province 
in northern Zimbabwe, where it was confined to the area 
along the border with Mozambique. The virus spread lo-
cally because of the salvage slaughter of infected pigs, the 
selling of infected pig meat at discounted prices, the move-
ment of pigs between villages, and the inappropriate dis-
posal of infectious carcasses.
During the 2015 outbreak in Zimbabwe, pigs with 
ASF exhibited fever (temperature 41°–42°C), dullness, an-
orexia, and swaying gait. Light-colored pigs also showed 
reddening of the skin on the ears and abdomen, but red-
ness was not evident on the indigenous black breed of pigs. 
Postmortem examinations revealed bloody discharge from 
the anus and nostrils; edema of the lungs; and hemorrhages 
in the mesenteric lymph nodes, kidney, and heart.
We pooled the organs from 3 infected pigs from 3 sepa-
rate villages in the outbreak area and extracted DNA. We 
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Figure. Neighbor-joining phylogenetic tree based on the partial 
B646L (p72) gene sequences of African swine fever virus (ASFV) 
isolates from a 2015 outbreak in Zimbabwe. The outbreak strains 
(ZIM/1/15, ZIM/2/15, and ZIM/3/15 [GenBank accession nos. 
KX090921–KX090923]) grouped with genotype II ASFV strains 
isolated in Mozambique (MOZ), Tanzania (TAN), Malawi (MAL), 
Mauritius (MAU), and Georgia, sharing 100% nucleotide identity 
with those strains. Phylogeny was inferred after 1,000 bootstrap 
replications; values at nodes indicate the percentage of bootstrap 
support. Scale bar indicates nucleotide substitutions per site.
amplified the variable 3′ end of the B646L (p72) gene by using 
2 oligonucleotide primers, p72-U and p72-D (3). To amplify 
the entire E183L gene (p54), we used primers described by 
Oviedo et al. (8), and to amplify the tetramer amino acid re-
peats within the hypervariable central variable region of the 
B602L gene, we used primers described by Gallardo et al. 
(5). Our results showed that sequences for all ASFV isolates 
from this outbreak and those for isolates previously collected 
in eastern Europe and eastern Africa were 100% homologous 
over the p72, p54, and central variable region gene-coding re-
gions. The p72 sequences clustered in genotype II (Figure).
During the 2015 ASFV outbreak in Zimbabwe, a total of 
3,427 pigs were at risk for infection in the affected area. Of 
those, 2,836 (≈83%) became infected, and all infected pigs 
died. The 591 pigs that did not become infected had been 
confined in pens and did not have exposure to infected pigs 
or their products. A follow-up study is under way in the re-
gion to genetically characterize the viruses in this outbreak, 
focusing on the p54, p30 and, central variable region genes.
All villages affected during the 2015 outbreak in Zim-
babwe were along the northern border with Mozambique, 
where genotype II has been found before. It is essential that 
more of the ASFVs circulating in eastern and southern Afri-
ca be sequenced so that their relatedness can be determined. 
This knowledge will enable the establishment of an epidemi-
ologic link between outbreaks in the region and underscore 
the need for adequate quarantine measures to prevent ASF 
from becoming endemic in southern and eastern Africa.
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Two cases of Bartonella prosthetic valve endocarditis were 
cured when treated for 2 weeks with gentamicin and 3 
months with doxycycline. Clinical cure correlated with de-
creased Bartonella antibody titers. This report suggests a 
strategy to monitor, treat, and cure Bartonella prosthetic 
valve endocarditis.
Bartonella, a causative agent of blood culture–negative endocarditis (BCNE) that usually requires valve sur-
gery, was first attributed to endocarditis over 20 years ago 
(1–4). We report 2 cases of Bartonella prosthetic valve en-
docarditis that were successfully treated with antimicrobial 
drugs alone.
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 5, May 2017 861
RESEARCH LETTERS
